Ascendis Pharma A (ASND) Return on Sales Growth (5y) (2019 - 2026)
Ascendis Pharma A (ASND) Return on Sales Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Ascendis Pharma A | 15.35 Bn | 14.68 Bn | 268.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 87.00 |
| Dec 31, 2025 | 2.00 |
| Sep 30, 2025 | 44.00 |
| Jun 30, 2025 | 66.00 |
| Mar 31, 2025 | 28.00 |
| Dec 31, 2024 | 2.00 |
| Sep 30, 2024 | 10.00 |
| Jun 30, 2024 | 15.00 |
| Mar 31, 2024 | 9.00 |
| Dec 31, 2023 | 1.00 |
| Sep 30, 2023 | -3.00 |
| Jun 30, 2023 | 1,263.00 |
| Mar 31, 2023 | 1,474.00 |
| Dec 31, 2022 | 113.00 |
| Sep 30, 2022 | 67.00 |
| Jun 30, 2022 | 56.00 |
| Mar 31, 2022 | 49.00 |
| Dec 31, 2021 | 14.00 |
| Sep 30, 2021 | -57.00 |
| Jun 30, 2021 | -120.00 |